Authors
Loading...
Preclinical study demonstrates successful repeat lung transduction using AAV6 vectors without cross-neutralization from AAV2 in mice, suggesting viable strategies for long-term pulmonary gene therapy.
Halbert et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: